CSS
Cubist Systematic Strategies Portfolio holdings
AUM $9.23B
1-Year Return
5.79%
This Quarter Return
-0.31%
1 Year Return
+5.79%
3 Year Return
+24.49%
5 Year Return
+69.08%
10 Year Return
+125.75%
AUM
$5.78B
AUM Growth
-$3B
(-34%)
Cap. Flow
-$2.92B
Cap. Flow
% of AUM
-50.51%
Top 10 Holdings %
Top 10 Hldgs %
10.9%
Holding
2,866
New
435
Increased
477
Reduced
428
Closed
1,202
Top Buys
| 1 |
General Motors
GM
|
+$68.2M |
| 2 |
Wells Fargo
WFC
|
+$57.3M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$50.3M |
| 4 |
Broadcom
AVGO
|
+$49.8M |
| 5 |
Snowflake
SNOW
|
+$49M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$76.5M |
| 2 |
Zoetis
ZTS
|
+$68.6M |
| 3 |
Uber
UBER
|
+$60M |
| 4 |
Netflix
NFLX
|
+$51M |
| 5 |
Micron Technology
MU
|
+$48.9M |
Sector Composition
| 1 | Technology | 19.84% |
| 2 | Industrials | 15.58% |
| 3 | Consumer Discretionary | 13.77% |
| 4 | Financials | 12.45% |
| 5 | Healthcare | 11.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Phreesia
PHR
$1.4B
| $99.6K | ﹤0.01% |
4,700
-99,921
| -96% | -$2.12M |
|
1177
Stitch Fix
SFIX
$727M
| $99.1K | ﹤0.01% |
+23,872
| New | +$99.1K |
|
1178
Mural Oncology
MURA
$35.9M
| $98.1K | ﹤0.01% |
+31,243
| New | +$98.1K |
|
1179
GoodRx Holdings
GDRX
$1.42B
| $97.1K | ﹤0.01% |
12,446
-479,249
| -97% | -$3.74M |
|
1180
MainStreet Bancshares
MNSB
$164M
| $96.6K | ﹤0.01% |
+5,450
| New | +$96.6K |
|
1181
NetEase
NTES
$99.5B
| $94.5K | ﹤0.01% |
989
-80,932
| -99% | -$7.74M |
|
|
GAU
1182
Galiano Gold
GAU
$659M
| $93.2K | ﹤0.01% |
54,163
+31,757
| +142% | +$54.6K |
|
|
SHCR
1183
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $92.5K | ﹤0.01% |
+68,501
| New | +$92.5K |
|
1184
Sportradar
SRAD
$8.86B
| $92.2K | ﹤0.01% |
8,249
-56,134
| -87% | -$628K |
|
|
ITI
1185
DELISTED
Iteris, Inc.
ITI
| $91.1K | ﹤0.01% |
+21,036
| New | +$91.1K |
|
1186
Butterfly Network
BFLY
$418M
| $90K | ﹤0.01% |
+106,995
| New | +$90K |
|
|
TWOU
1187
DELISTED
2U, Inc.
TWOU
| $87.9K | ﹤0.01% |
+17,125
| New | +$87.9K |
|
1188
Neuropace
NPCE
$325M
| $87.1K | ﹤0.01% |
11,519
-39,206
| -77% | -$296K |
|
1189
Digi International
DGII
$1.33B
| $86.3K | ﹤0.01% |
+3,766
| New | +$86.3K |
|
1190
Waldencast
WALD
$215M
| $84.6K | ﹤0.01% |
+23,570
| New | +$84.6K |
|
1191
Latham Group
SWIM
$916M
| $84.6K | ﹤0.01% |
27,923
+11,601
| +71% | +$35.2K |
|
1192
Broadwind
BWEN
$49.1M
| $84.3K | ﹤0.01% |
+25,713
| New | +$84.3K |
|
|
INZY
1193
DELISTED
Inozyme Pharma
INZY
| $84.3K | ﹤0.01% |
+18,891
| New | +$84.3K |
|
1194
Funko
FNKO
$183M
| $83.8K | ﹤0.01% |
8,584
-6,354
| -43% | -$62K |
|
1195
5E Advanced Materials
FEAM
$87.3M
| $82.8K | ﹤0.01% |
+2,976
| New | +$82.8K |
|
1196
Y-mAbs Therapeutics
YMAB
$391M
| $79.7K | ﹤0.01% |
6,597
-71,189
| -92% | -$860K |
|
|
ABVX
1197
Abivax
ABVX
$6.22B
| $79.7K | ﹤0.01% |
6,027
-7,995
| -57% | -$106K |
|
1198
Atara Biotherapeutics
ATRA
$83.9M
| $78.8K | ﹤0.01% |
+9,271
| New | +$78.8K |
|
1199
Design Therapeutics
DSGN
$334M
| $78.7K | ﹤0.01% |
23,497
+10,113
| +76% | +$33.9K |
|
1200
Crexendo
CXDO
$196M
| $76.2K | ﹤0.01% |
24,228
-28,668
| -54% | -$90.2K |
|